Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.97
-0.04 (-0.36%)
At close: May 22, 2026, 4:00 PM EDT
10.99
+0.02 (0.18%)
After-hours: May 22, 2026, 5:28 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $685.15 million as of May 22, 2026. Its market cap has increased by 242.88% in one year.
Market Cap
685.15M
Enterprise Value
465.06M
1-Year Change
242.88%
Ranking
Category
Stock Price
$10.97
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $685.15M, a decrease of -68.94%. That is a compound annual growth rate of -20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 685.15M | 28.23% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 743.82M |
| Relmada Therapeutics | 738.41M |
| Tenax Therapeutics | 714.19M |
| SpyGlass Pharma | 696.61M |
| Allogene Therapeutics | 690.31M |
| Crescent Biopharma | 689.17M |
| BridgeBio Oncology Therapeutics | 684.92M |
| Solid Biosciences | 651.74M |